UNSPSC 51422216: Triamcinolone hexacetonide

This classification denotes a therapeutic glucocorticoid with the molecular formula C30H41FO7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I7GT1U99Y9, chemically known as 9-fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone 21-(3,3-dimethylbutyrate) but more generally known as triamcinolone hexacetonide, which bears US NIH Compound Identifier 21826.

UNSPSC 51422216 Triamcinolone hexacetonide, a Commodity code, shows a significant mismatch between its nominal scope and the recent state and local opportunities posted under it. The code nominally identifies a specific corticosteroid pharmaceutical product, but the two most recent solicitations tagged to this code are pursuing entirely unrelated procurements: Seminole County, Florida is bidding Naloxone and drug deactivation systems for community health delivery, and the Texas Health and Human Services Commission has issued a request for information on direct-to-manufacturer prescription fulfillment programs. Neither solicitation addresses triamcinolone hexacetonide or its pharmaceutical class. The mismatch suggests either a data-taxonomy error in how these opportunities were classified or a broader tag applied to cover multiple pharmaceutical-acquisition initiatives across health agencies.

Activity under this code appears minimal and materially misaligned with its stated commodity scope. The Seminole County IFB, posted June 30, 2026 with a response deadline of July 26, 2023 (a date conflict in the source), requests 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually on a two-year term with one-year renewal option; the Texas HHS RFI, posted April 3, 2026, is exploratory market intelligence on pharmacy benefit direct-contracting models with no award value or formal competitive timeline. No budget figures, formal set-asides, or second-source activity appears in the record. Unless the code is a catch-all classifier for state health-agency pharmaceutical or medical-supply procurement more broadly—a signal worth testing with procurement offices directly—this code shows little concrete opportunity for vendors focused on triamcinolone hexacetonide or comparable pharmaceutical products.